All News Zelira Therapeutics Limited

Equities

ZLD

AU000000ZLD1

Market Closed - Australian S.E. Other stock markets 01:58:07 2024-07-16 am EDT			5-day change	1st Jan Change
1.05 ^AUD	+31.25%		+169.23%	+16.67%

04:13am	Zelira Therapeutics Jumps 25% After Securing Australian Patents for Autism Formulations	MT
Jul. 11	Zelira Therapeutics Secures US FDA Guidance for Autism Spectrum Disorder Therapy Program; Shares Surge 24%	MT

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zelira Therapeutics Jumps 25% After Securing Australian Patents for Autism Formulations	10:13pm	MT
Zelira Therapeutics Secures US FDA Guidance for Autism Spectrum Disorder Therapy Program; Shares Surge 24%	Jul. 10	MT
Zelira Therapeutics Receives $1.4 Million Unsecured Loan from Chairman	Jul. 04	MT
Zelira Therapeutics Limited announced that it has received $1.4 million in funding	Jul. 03	CI
Zelira Therapeutics Obtains $1.4 Million Loan from Chairman	Jul. 01	MT
Zelira Therapeutics Limited announced that it expects to receive $1.4 million in funding	Jun. 30	CI
Zelira Therapeutics Receives Third-Tranche of Funding for HOPE Clinical Trials	May. 22	MT
Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government’s R&D Tax Incentive Scheme	Apr. 14	MT
Zelira Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22	CI
Zelira Therapeutics Secures Grant Funding for Cannabinoid Product	Jan. 07	MT
Transcript : Zelira Therapeutics Limited - Shareholder/Analyst Call	Nov. 14
Zelira Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Zelira Therapeutics Limited Announces Board Changes	23-05-31	CI
Transcript : Zelira Therapeutics Limited - Special Call	23-05-30
Zelira Therapeutics Bags Nearly AU$5 Million More Investment for HOPE SPV; Shares Rise 4%	23-05-21	MT
Zelira Therapeutics Limited announced that it expects to receive $22 million in funding	23-05-21	CI
Zelira Therapeutics Raises AU$1.8 Million Via Placement	23-03-15	MT
Zelira Therapeutics Halts Securities Trading Pending Capital Raising Announcement	23-03-13	MT
Zelira Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI
Transcript : Zelira Therapeutics Limited - Special Call	23-02-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Zelira Therapeutics Limited

Equities

ZLD

AU000000ZLD1

All News

Filters